Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
Thomas Jefferson University
Alliance for Clinical Trials in Oncology
National Institutes of Health Clinical Center (CC)
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
University of Washington
Peking Union Medical College Hospital
Yantai LNC Biotechnology Singapore PTE. LTD.
Emory University
Eastern Cooperative Oncology Group
Peking University First Hospital
Peking University Cancer Hospital & Institute
Vanderbilt-Ingram Cancer Center
Jonsson Comprehensive Cancer Center
Stanford University
Stanford University
European Organisation for Research and Treatment of Cancer - EORTC
Ohio State University Comprehensive Cancer Center
Roswell Park Cancer Institute
Cancer Trials Ireland
University of Washington
Genentech, Inc.
National Cancer Institute (NCI)
University of Washington
Virginia Commonwealth University
Shanghai Chest Hospital
Alliance for Clinical Trials in Oncology
Stanford University
Xijing Hospital
AHS Cancer Control Alberta
National Cancer Institute (NCI)
Cell>Point LLC
Cell>Point LLC
Memorial Sloan Kettering Cancer Center
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Maastricht Radiation Oncology